Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAFF |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → MAFF |
| (<<) ALDOA → MAFF |
| (<<) ANXA2 → MAFF |
| (<<) CBS → MAFF |
| (<<) CYP1A2 → MAFF |
| (<<) CYP4F2 → MAFF |
| (<<) PCK2 → MAFF |
| (<<) RDH16 → MAFF |
| (<<) SAA4 → MAFF |
| (<<) TMSB10 → MAFF |
| Downstream (Children) |
|---|
| MAFF → ADAM9 (>>) |
| MAFF → ARSA (>>) |
| MAFF → CEBPA (>>) |
| MAFF → CREB5 (>>) |
| MAFF → CYP1A1 (>>) |
| MAFF → DUSP5 (>>) |
| MAFF → EMP1 (>>) |
| MAFF → ENO2 (>>) |
| MAFF → FOS (>>) |
| MAFF → GOT2 (>>) |
| MAFF → GPR109B (>>) |
| MAFF → HBEGF (>>) |
| MAFF → HK2 (>>) |
| MAFF → IER3 (>>) |
| MAFF → IL1B (>>) |
| MAFF → ITGA2 (>>) |
| MAFF → LIF (>>) |
| MAFF → MAP2K1 (>>) |
| MAFF → MLXIPL (>>) |
| MAFF → MMP12 (>>) |
| MAFF → MTHFD2 (>>) |
| MAFF → MYO1E (>>) |
| MAFF → NDRG1 (>>) |
| MAFF → NEDD4 (>>) |
| MAFF → PDK2 (>>) |
| MAFF → PFKFB3 (>>) |
| MAFF → PHLDA2 (>>) |
| MAFF → PITPNC1 (>>) |
| MAFF → PKM2 (>>) |
| MAFF → PLAUR (>>) |
| MAFF → PLK3 (>>) |
| MAFF → PTPRE (>>) |
| MAFF → RHOA (>>) |
| MAFF → RXRA (>>) |
| MAFF → SLC20A1 (>>) |
| MAFF → STK17B (>>) |
| MAFF → STX1A (>>) |
| MAFF → TAF1A (>>) |
| MAFF → TAGLN2 (>>) |
| MAFF → TSPAN3 (>>) |
| MAFF → TTC9 (>>) |
